Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
ARS Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $9.43
+14% in 7d after detection
Post-detection moves
1h
—
1d
-1.7%
3d
+5.1%
7d
+14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS